- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 112
Proxymity pulls in $20.5m
Citi-founded shareholder communication portal creator Proxymity has raised an initial $20.5m sum to expand its software and target additional markets.
May 6, 2020Medable mediates $25m
PPD has backed clinical trial preparation software developer Medable as an existing investor having also partnered the business to launch a telemedicine-based clinical trial product last year.
May 6, 2020Near Protocol collates fresh funding
The blockchain software deployment service has raised $21.6m to follow a series A round last year that included contributions from Coinbase Ventures, Ideo Colab Ventures and Ripple's Xpring.
May 6, 2020Zeitgold treasures series B funding
Deutsche Bank and Axa Innovation Campus featured in a $29.2m round that brought enterprise book-keeping app developer Zeitgold's funding haul to approximately $57m.
May 5, 2020ZAF Energy stores $22m
ZAF Energy Systems has raised $45.6m to date after a series A round that featured the corporate venture capital arm of Holt Cat.
May 5, 2020Vida Health inspires $25m commitment
Workday Ventures returned for a $25m funding round for the online healthcare portal, whose shareholders also include GuideWell Mutual and Teladoc.
May 4, 2020InsideBoard inserts series B funding
Axa Venture Partners and Orange Digital Ventures backed a $27.2m round that will fund product development and international growth for the employee engagement software provider.
May 1, 2020Salesforce slots into Niche for $35m series C
Salesforce Ventures has thrown its weight behind Niche as the educational matchmaking service prepares to add thousands of schools to its platform.
Apr 30, 2020Taysha stakes out $30m seed round
UT Southwestern has formed central nervous system diseases treatment developer Taysha Gene Therapies with executives who previously worked for OSU's Avexis.
Apr 30, 2020Actym Therapeutics actions $34m
Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.
Apr 29, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


